Matches in SemOpenAlex for { <https://semopenalex.org/work/W2911659871> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W2911659871 abstract "43 Background: Platinum and 5-Fluorouracil (5FU) neoadjuvant chemotherapy followed by surgery is one of the standard approaches for patients with resectable EAC. To date, there are no predictive biomarkers of chemotherapy benefit. We hypothesize that DNA methylation of genes in key biologic and oncogenic pathways predict for chemotherapy benefit in EAC. Methods: In the OE02 trial, 802 patients with resectable esophageal carcinoma were randomised to surgery alone (S) versus two cycles of cisplatin and 5FU chemotherapy followed by surgery (CS). DNA was extracted from 213 EAC resection specimens (110 from the (CS) arm, 103 from the (S) arm). DNA methylation was analyzed at 1505 CpG sites within 807 genes using the Illumina GoldenGate platform. Cox proportional hazard analysis was performed to identify predictive markers of survival in (CS) arm; non-negative matrix factorization (NMF) was used to delineate methylation signatures. Results: Methylation status of 1505 CpG sites had no statistical difference between the (CS) and (S) arms. In the (CS) arm, 87 (5.7%) CpG sites were initially identified as promising candidates in univariate analysis (p < 0.05 cutoff). NMF generated a 4 CpG site signature which divided patients into poor risk and good risk. Genes involved in the signature include RUNX1T1, CCND2, MST1R and MMP14. Survival was significantly different between poor risk and good risk in (CS) arm (HR 0.32, 95% CI: 0.21 to 0.52, p < 0.0001). No difference in survival was detected in the surgery arm (HR 1.12, 95% CI: 0.76 to 1.80, p = 0.48), suggesting the signature served as a predictive and not prognostic biomarker. Methylation signature remained an independent predictor of survival in multivariate analysis with clinicopathologic factors (along with age and vascular invasion). Conclusions: Chemotherapy does not appear to change methylation status of EAC. Hypermethylation of RUNX1T1, CCND2 and hypomethylation of MST1R and MMP14 leads to significantly decreased benefit from chemotherapy in EA. We describe an epigenetic signature which may serve as a predictive biomarker for chemotherapy benefit using data form the largest bank of DNA methylation in EA reported to date." @default.
- W2911659871 created "2019-02-21" @default.
- W2911659871 creator A5008643917 @default.
- W2911659871 creator A5010740611 @default.
- W2911659871 creator A5011703751 @default.
- W2911659871 creator A5012410958 @default.
- W2911659871 creator A5012677471 @default.
- W2911659871 creator A5017137833 @default.
- W2911659871 creator A5018056806 @default.
- W2911659871 creator A5019453132 @default.
- W2911659871 creator A5053619368 @default.
- W2911659871 creator A5056345420 @default.
- W2911659871 creator A5057894542 @default.
- W2911659871 creator A5059272387 @default.
- W2911659871 creator A5059995755 @default.
- W2911659871 creator A5060331679 @default.
- W2911659871 creator A5075852881 @default.
- W2911659871 date "2019-02-01" @default.
- W2911659871 modified "2023-10-15" @default.
- W2911659871 title "DNA methylation signature predictive of benefit from neoadjuvant chemotherapy in esophageal adenocarcinoma: Results from the MRC OEO2 phase III trial." @default.
- W2911659871 doi "https://doi.org/10.1200/jco.2019.37.4_suppl.43" @default.
- W2911659871 hasPublicationYear "2019" @default.
- W2911659871 type Work @default.
- W2911659871 sameAs 2911659871 @default.
- W2911659871 citedByCount "1" @default.
- W2911659871 countsByYear W29116598712021 @default.
- W2911659871 crossrefType "journal-article" @default.
- W2911659871 hasAuthorship W2911659871A5008643917 @default.
- W2911659871 hasAuthorship W2911659871A5010740611 @default.
- W2911659871 hasAuthorship W2911659871A5011703751 @default.
- W2911659871 hasAuthorship W2911659871A5012410958 @default.
- W2911659871 hasAuthorship W2911659871A5012677471 @default.
- W2911659871 hasAuthorship W2911659871A5017137833 @default.
- W2911659871 hasAuthorship W2911659871A5018056806 @default.
- W2911659871 hasAuthorship W2911659871A5019453132 @default.
- W2911659871 hasAuthorship W2911659871A5053619368 @default.
- W2911659871 hasAuthorship W2911659871A5056345420 @default.
- W2911659871 hasAuthorship W2911659871A5057894542 @default.
- W2911659871 hasAuthorship W2911659871A5059272387 @default.
- W2911659871 hasAuthorship W2911659871A5059995755 @default.
- W2911659871 hasAuthorship W2911659871A5060331679 @default.
- W2911659871 hasAuthorship W2911659871A5075852881 @default.
- W2911659871 hasConcept C104317684 @default.
- W2911659871 hasConcept C121608353 @default.
- W2911659871 hasConcept C126322002 @default.
- W2911659871 hasConcept C143998085 @default.
- W2911659871 hasConcept C150194340 @default.
- W2911659871 hasConcept C190727270 @default.
- W2911659871 hasConcept C207103383 @default.
- W2911659871 hasConcept C2776694085 @default.
- W2911659871 hasConcept C2778292576 @default.
- W2911659871 hasConcept C2781182431 @default.
- W2911659871 hasConcept C33288867 @default.
- W2911659871 hasConcept C44249647 @default.
- W2911659871 hasConcept C50382708 @default.
- W2911659871 hasConcept C530470458 @default.
- W2911659871 hasConcept C55493867 @default.
- W2911659871 hasConcept C71924100 @default.
- W2911659871 hasConcept C86803240 @default.
- W2911659871 hasConceptScore W2911659871C104317684 @default.
- W2911659871 hasConceptScore W2911659871C121608353 @default.
- W2911659871 hasConceptScore W2911659871C126322002 @default.
- W2911659871 hasConceptScore W2911659871C143998085 @default.
- W2911659871 hasConceptScore W2911659871C150194340 @default.
- W2911659871 hasConceptScore W2911659871C190727270 @default.
- W2911659871 hasConceptScore W2911659871C207103383 @default.
- W2911659871 hasConceptScore W2911659871C2776694085 @default.
- W2911659871 hasConceptScore W2911659871C2778292576 @default.
- W2911659871 hasConceptScore W2911659871C2781182431 @default.
- W2911659871 hasConceptScore W2911659871C33288867 @default.
- W2911659871 hasConceptScore W2911659871C44249647 @default.
- W2911659871 hasConceptScore W2911659871C50382708 @default.
- W2911659871 hasConceptScore W2911659871C530470458 @default.
- W2911659871 hasConceptScore W2911659871C55493867 @default.
- W2911659871 hasConceptScore W2911659871C71924100 @default.
- W2911659871 hasConceptScore W2911659871C86803240 @default.
- W2911659871 hasLocation W29116598711 @default.
- W2911659871 hasOpenAccess W2911659871 @default.
- W2911659871 hasPrimaryLocation W29116598711 @default.
- W2911659871 hasRelatedWork W2033096478 @default.
- W2911659871 hasRelatedWork W2033359203 @default.
- W2911659871 hasRelatedWork W2040350626 @default.
- W2911659871 hasRelatedWork W2207624802 @default.
- W2911659871 hasRelatedWork W2328845621 @default.
- W2911659871 hasRelatedWork W2381496852 @default.
- W2911659871 hasRelatedWork W2602269157 @default.
- W2911659871 hasRelatedWork W2606443396 @default.
- W2911659871 hasRelatedWork W2758804317 @default.
- W2911659871 hasRelatedWork W3120449673 @default.
- W2911659871 isParatext "false" @default.
- W2911659871 isRetracted "false" @default.
- W2911659871 magId "2911659871" @default.
- W2911659871 workType "article" @default.